Dark Forest Capital Management LP Recursion Pharmaceuticals, Inc. Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$6.59 - $15.86 $182,760 - $439,845	-27,733 Reduced 61.23%	17,561 $134,000
Q2 2023 Aug 14, 2023	SELL	$4.56 - $9.94 $31,796 - $69,311	-6,973 Reduced 13.34%	45,294 $338,000
Q1 2023 May 12, 2023	BUY	$6.42 - $9.64 $331,169 - $497,269	51,584 Added 7552.56%	52,267 $348,000
Q4 2022 Feb 13, 2023	BUY	$7.16 - $12.7 $4,890 - $8,674	683 New	683 $5,000
Q2 2022 Aug 15, 2022	BUY	$5.04 - $9.26 $4,238 - $7,787	841 New	841 $7,000

289

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.18B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.